Atlas Energy Corp. logo

Atlas Energy Corp. (CANSF)

Market Closed
10 Aug, 20:00
OTCQB OTCQB
$
0. 08
0
0%
$
46.49M Market Cap
- P/E Ratio
- Div Yield
5,000 Volume
- Eps
$ 0.08
Previous Close
Add Transaction
Day Range
0.08 0.11
Year Range
0.05 0.15
Want to track CANSF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CANSF closed today higher at $0.08, an increase of 0% from yesterday's close, completing a monthly decrease of -34.4262% or -$0.04. Over the past 12 months, CANSF stock lost -34.9594%.
CANSF is not paying dividends to its shareholders.
The last earnings report, released on Mar 31, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0003%, based on the last three reports.
Atlas Energy Corp. has completed 4 stock splits, with the recent split occurring on Jun 24, 2025.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on TSX-V (CAD).

CANSF Chart

People also search for

International Isotopes Inc.
$ 0.07
+16.6667%
Starco Brands Inc.
$ 0.04
+8.5714%
Noble Roman's Inc.
$ 0.68
-1.4493%
Fluent Corp.
$ 0.02
-12%
Adm Endeavors Inc.
$ 0.04
-13.242%

Atlas Energy Corp. (CANSF) FAQ

What is the stock price today?

The current price is $0.08.

On which exchange is it traded?

Atlas Energy Corp. is listed on OTCQB.

What is its stock symbol?

The ticker symbol is CANSF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 46.49M.

Has Atlas Energy Corp. ever had a stock split?

Atlas Energy Corp. had 4 splits and the recent split was on Jun 24, 2025.

Atlas Energy Corp. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mark Alan Hodgson CEO
OTCQB Exchange
CA0489241046 ISIN
CA Country
19 Employees
- Last Dividend
24 Jun 2025 Last Split
- IPO Date

Overview

Willow Biosciences Inc. is a trailblazing biotechnology company focused on the development, production, and commercialization of plant-derived ingredients critical for consumer care, food and beverage, and pharmaceutical industries. Established in 2019 and based in Calgary, Canada, the company leverages the latest advancements in biotechnology to innovate in the field of natural ingredient synthesis. Willow Biosciences operates primarily within the United States but has fostered global partnerships, such as with SUANFARMA for the development of anti-infective API through precision fermentation, and with Laurus Labs for the manufacturing of active pharmaceutical ingredients. These collaborations underscore Willow Biosciences’ commitment to cutting-edge research and its capabilities in bringing high-quality, plant-derived ingredients to market.

Products and Services

  • Consumer Care Ingredients

    Willow Biosciences specializes in creating high-purity, plant-derived ingredients for use in various consumer care products. Leveraging biotechnological innovations, the company offers environmentally sustainable and ethically produced alternatives to traditional chemically synthesized ingredients.

  • Food and Beverage Ingredients

    Understanding the growing consumer demand for natural and healthy ingredients, Willow Biosciences develops and supplies plant-derived ingredients that can be incorporated into food and beverage products. These ingredients are designed to enhance nutritional value without compromising taste or quality.

  • Pharmaceutical Ingredients

    Through its expertise in biotechnology, Willow Biosciences produces active pharmaceutical ingredients (APIs) with a focus on precision, quality, and scalability. The company's collaboration with Laurus Labs enhances its capability to supply these critical components for pharmaceutical manufacturing, including APIs with anti-infective properties developed through a partnership with SUANFARMA.

Contact Information

Address: 202, 1201-5th Street SW
Phone: 403 910 5140